Implementing Biologics in COPD: Overcoming Challenges and Embedding the BTS Planning Framework Following Dupilumab Introduction

Implementing Biologics in COPD: Overcoming Challenges and Embedding the BTS Planning Framework Following Dupilumab Introduction

Dr Laura-Jane Smith, Consultant Respiratory Physician at King’s College Hospital NHS Foundation Trust, and Samantha Workman, Lead Specialist Respiratory Pharmacist at Royal Sussex County Hospital, explored the practical challenges of introducing biologic therapies for chronic obstructive pulmonary disease (COPD), and shared strategies for embedding these innovative treatments into routine clinical practice.

Their joint presentation reviewed the emerging evidence for biologic therapies, the latest NICE recommendations and the operational realities of delivering equitable access across different healthcare settings.

They discussed the importance of multidisciplinary collaboration, standardised care pathways and homecare services to ensure biologics are introduced safely and sustainably. Their presentation demonstrated how careful planning, shared governance and phased implementation can help overcome resource constraints while improving outcomes for patients with severe COPD.

Back to other blogs